Tom Winnifrith Bearcast: Time to double up on the Shield Therapeutics final collapse, the money's almost all gone!
By Tom Winnifrith | Tuesday 7 June 2022
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
On 18 February, at 25.5p to sell, the big bear call was greeted with abuse from BB savants, who, unsurprisingly, always know better. Shares in Shield (STX) are now 14.6p, and the final collapse to c. 5p is now set to begin. Double up on your shorts. In this podcast, I discuss Argo Blockchain (ARB); Nostra Terra Oil & Gas (NTOG) and its unsavoury CEO, Matt Lofgran - praise be the Lord; then, I look at Genflow Biosciences (GENF), as its shares continue to tank; Challenger Energy (CHAL); Eurasia Mining (EUA); and Petropavlovsk (POG), where the target remains 0p. Finally, I remind you that Rogue Bloggers for Woodlarks is just 4 days away, and we are at 34% of the target. If among the 92% of listeners yet to donate, do give a fiver (or a tenner), HERE.
You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism
Join us for free and gain access to three articles per month
Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.